医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Advantech Withdraws Participation to Embedded World 2020 Due to CoronaVirus Health and Safety Concerns

2020年02月24日 PM10:56
このエントリーをはてなブックマークに追加


 

MUNICH

In response to the current outbreak of novel coronavirus (COVID-19), Advantech (stock code: 2395), global leader in IoT, wants to inform its customers, partners and employees that we have regretfully decided to withdraw our participation to Embedded World (February 25th -27th) and all activities scheduled for this event.. For Advantech, the health of our employees, customers and partners is of the utmost importance. We would like to thank the Nürnberg Messe GmbH for its support and understanding.

– Ends –

About Embedded-IoT Group

As leader in the embedded market, the Advantech Embedded-IoT group not only delivers a wide range of embedded design-in services but also develops a series of integrated IoT solutions and services to minimize uncertainty and risk for customers approaching the IoT market. Advantech Integrated IoT Solutions include everything from sensor nodes, to gateways, to WISE-PaaS IoT software and much more. (Embedded-IoT.advantech.com)

About Advantech

Advantech’s corporate vision is to enable an intelligent planet. The company is a global leader in the fields of IoT intelligent systems and embedded platforms. To embrace the trends of IoT, big data, and artificial intelligence, Advantech promotes IoT hardware and software solutions with the Edge Intelligence WISE-PaaS core to assist business partners and clients in connecting their industrial chains. Advantech is also working with business partners to co-create business ecosystems that accelerate the goal of industrial intelligence. (www.advantech.com)

View source version on businesswire.com: https://www.businesswire.com/news/home/20200224005567/en/

CONTACT

Press Contact eIoT:

Advantech Europe B.V.

Daniel Piper

Tel: +49 173 659 9848

daniel.piper@advantech.de

Press Contact Corporate Europe

Advantech Europe B.V.

Karla Ferrer

Tel: +33 (0) 141 19 79 22

Karla.ferrer@advantech.fr

Press Contact Corporate Headquarters

Jennifer Huang

Tel: +886 2 2792-7818 ext.7388

Jennifer.huang@advantech.tw

同じカテゴリーの記事 

  • joimax® Obtains Registration for All Products in the Indian Market
  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China
  • Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights
  • エクセルゲン、バクスター・インターナショナルを提訴。口腔体温計の精度に関するデータの公表権を擁護
  • パース・バイオサイエンシズが研究室用自動化プロバイダー・プログラムをローンチし、ハミルトン、オープントロンズ、ラボワークス、SPTラボテックと提携